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Abstract Purpose: Intrapulmo-
nary percussive ventilation (IPV) is a
high-frequency ventilation modality
that can be superimposed on sponta-
neous breathing. IPV may diminish
respiratory muscle loading and help
to mobilize secretions. The aim of
this prospective study was to assess
the short-term effects of IPV in
patients at high risk for extubation
failure who were receiving preventive
non-invasive ventilation (NIV) after
extubation. Methods: Respiratory
rate, work of breathing, and gas
exchange were evaluated in 17 extu-
bated patients during 20 min of IPV
and 20 min of NIV delivered via a
facial mask, separated by periods of
spontaneous breathing. The pressure-
support level during NIV was adjus-
ted until tidal volume reached
6–8 ml/kg and positive end-expira-
tory pressure (PEEP) 4–5 cmH2O.
For IPV, the pressurisation frequency
was set at 250 cycles/min and driving
pressure at 1.2 bar. The pressure–
time product of the diaphragm
(PTPdi/min) was measured using
an oesophageal and gastric double-
balloon catheter. Results: Transdia-
phragmatic pressure and PTPdi/min
improved significantly (p \ 0.01),
from a median [25th–75th percen-
tiles] of 264 [190–300] to 192
[152–221] cmH2O s/min with IPV
and from 273 [212–397] to 176
[120–216] cmH2O s/min with NIV.
Respiratory rate decreased signifi-
cantly from 23 [19–27] to 22 [17–24]
breaths/min for IPV and from 25
[19–28] to 20 [18–22] breaths/min
for NIV (p \ 0.01). Mean PaCO2
decreased after NIV (from 46 [42–48]
to 41 [36–42] mmHg, p \ 0.01) but
not after IPV. There was no notice-
able effect on oxygenation.
Conclusions: IPV is an interesting
alternative to NIV in patients at risk
for post-extubation respiratory fail-
ure. Both NIV and IPV diminished
the respiratory rate and work of
breathing, but IPV was less effective
in improving alveolar ventilation.
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Introduction
Post-extubation respiratory failure is a major clinical
problem in intensive care unit (ICU) patients. Approxi-
mately 10 to 20% of extubated patients may require re-
intubation [1] and the in-hospital mortality of these
patients may reach 30–40% [2, 3]. Experts at an inter-
national consensus conference described non-invasive
ventilation (NIV) as holding promise for preventing re-
intubation after extubation failure [4]. Randomised trials
[5, 6] have been performed to assess whether NIV pre-
vented post-extubation failure in high-risk patients.
Several studies that used comparable definitions of high-
risk patients and similar study designs showed lower re-
intubation rates in the groups given preventive NIV
compared to those given standard care. In a randomised
controlled trial, preventive NIV diminished ICU and
90-day mortality rates in the subgroup of hypercapnic
patients [7]. Thus, prompt initiation of a 48-h period of
NIV in high-risk patients decreases the risk of post-
extubation respiratory failure.
Intrapulmonary percussive ventilation (IPV) delivers
high-frequency mini-bursts of high-flow gas that are
superimposed on the spontaneous breathing pattern. IPV
may improve gas exchange and secretion clearance [8].
Percussion frequency, timing, and driving pressure must
be adjusted, but no specific adaptation to the patient’s
breathing pattern is required [9]. IPV was first used by
physiotherapists for secretion removal in patients with
Duchenne muscular dystrophy [10], cystic fibrosis [11], or
atelectasis [12]. This safe, intermittent, and simple tech-
nique has been shown to produce some degree of
diaphragmatic unloading in patients with chronic
obstructive pulmonary disease (COPD) who are stable or
experiencing a mild exacerbation [13, 14]. Compared to
NIV, IPV is superimposed on spontaneous breathing
during the whole respiratory cycle with no synchronisa-
tion required between the patient’s own breathing.
The aim of this prospective study was to assess the
short-term physiologic effects of an IPV session in




A prospective physiological study was conducted in the
ICU of the Henri Mondor University Hospital, Cre´teil,
France. The experimental protocol was approved by the
appropriate ethics committee (Comite´ de Protection des
Personnes IX Cre´teil) and informed consent was obtained
from patients or next of kin.
Inclusion criteria
All patients who required orotracheal intubation for 48 h
or longer and who tolerated a spontaneous breathing trial
after recovery from their acute episode were considered
eligible for the study if they had at least two of the fol-
lowing risk factors for post-extubation respiratory failure
[5]: age older than 65 years, underlying heart or respira-
tory failure, and Acute Physiology and Chronic Health
Evaluation (APACHE) II [15] score greater than 12 on the
day of extubation. Tracheostomised patients were not
screened for the study. In our ICU, post-extubation NIV is
used in all patients having at least two of these three
criteria.
Exclusion criteria were related to NIV and to the
insertion of a double-balloon catheter: facial or cranial
trauma or surgery, recent gastric or oesophageal surgery,
active upper gastrointestinal bleeding, lack of coopera-
tion, and a decision to limit treatment intensity in the ICU.
Study design and measurements
Patients meeting weaning criteria (see details in the
‘‘Electronic supplementary material’’, ESM) had a spon-
taneous breathing trial (T-piece or low-pressure support
with no positive end-expiratory pressure, PEEP) once a
day. When the trial was well tolerated, the patient was
extubated and enrolled in the study. Before extubation, a
double-balloon catheter was positioned to record
oesophageal and gastric pressures.
Five study sessions were performed after extubation.
Within 2 h after extubation, NIV and IPV were tested, in
random order, via a face mask (Performatrak, Philips
Respironics, Murrysville, PA, USA). The IPV and NIV
sessions lasted 20 min. The other three sessions were
periods of spontaneous breathing before, between, and
after the NIV and IPV sessions.
Intrapulmonary percussive ventilation
IPV is a high-frequency ventilation modality that delivers
subphysiological tidal volumes at rates higher than 1 Hz.
The bursts are produced by a sliding venturi (the Phasi-
tron) [21] powered by compressed gas whose pressure
can be varied between 0.8 to 3.5 bar and that generates
oscillations between 80 and 650 cycles/min. The venturi
effect drags humidified gas from a nebuliser through the
Phasitron to the patient. A continuous positive pressure is
maintained, while the high-velocity percussive inflow
opens the airways and enhances intrabronchial secretion
mobilization. We chose the 1.2 bar/250 cycles/min
setting on the basis of previous results by Nava et al.
[13].
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In our study, IPV was delivered by a specific ventilator
(IPV1-C device, Percussionnaire Corporation, Sand-
point, ID, USA) (see Fig. S1 in the ESM) through a face
mask. The pressurisation frequency was set at 250 cycles/
min and driving pressure at 1.2 bar. The inspiration/
expiration ratio of the oscillatory flow generated by the
device (independent of the patient’s breathing pattern)
was set at 1/2.5.
Humidification was provided via the nebuliser rec-
ommended by the IPV device manufacturer. The
nebuliser was inserted in the circuit and 10 ml of saline
solution was delivered for humidification. The oxygen
fraction was adjusted using a blender.
Non-invasive ventilation
All patients were ventilated using an ICU ventilator
capable of providing NIV. The ventilator was set in
pressure-support mode with PEEP. The pressure-support
level was adjusted until tidal volume reached 6–8 ml/kg.
PEEP was set at 4 or 5 cmH2O. The inspiratory trigger
was set between 1 and 3 l/min, pressurisation slope at
80%, and inspiratory–expiratory cycling at 25% of peak
flow.
Data collection and recordings
The following variables were collected at enrolment: age,
gender, reasons for mechanical ventilation, and severity
of illness status assessed using APACHE II. The double-
balloon catheter was filled with 1 ml of air for the gastric
balloon and 0.5 ml of air for the oesophageal balloon.
Balloon position was checked using the occlusion test and
the abdominal manoeuvre [16]. The physiological vari-
ables were displayed continuously on a computer screen.
Oxygen saturation via a pulse oximeter (SpO2), heart rate
(HR), and respiratory rate (RR) were monitored using an
ICU monitor.
A heated pneumotachograph (Fleisch no.2, Lausanne,
Switzerland) connected to a differential pressure trans-
ducer (Validyne MP45, 80 cmH2O, Northridge, CA,
USA) was placed between the mask and ventilator tubing
to measure flow at the airway opening. Tidal volume was
obtained by digital integration of the flow (Fig. 1). Air-
way pressure was measured from a side port between the
pneumotachograph and face mask.
Transdiaphragmatic pressure (Pdi) was calculated
electrically by subtracting the oesophageal pressure
signal (Poes) from the gastric pressure (Pga) signal [16,
17]. The pressure–time product of the diaphragm was
calculated per breath by integration of the transdia-
phragmatic pressure signal per breath (PTPdi/b) and per
minute (PTPdi/min). PTPdi/b was obtained by measuring
the area under the Pdi signal from the onset of its
positive deflection to its return to baseline. PTPdi/min
was obtained by multiplying PTPdi/breath by the respi-
ratory rate [16, 17].
Arterial blood gas values were measured (ABL 520
Radiometer, Copenhagen, Denmark) after each of the five
study sessions in the patients who already had an arterial
catheter. In the other patients, no blood samples were
drawn.
The patients were asked to evaluate comfort during
NIV and IPV using the following scale: 1, severe dis-
comfort; 2, discomfort; 3, acceptable level of comfort; 4,
good level of comfort; 5, very good level of comfort.
Fig. 1 Schematic representation of the circuit. Intrapulmonary
percussive ventilation (IPV) provides a pulsatile flow; the Phasi-
tron (1) in the IPV uses a sliding flow based on the venturi effect.
Gas from the nebuliser is dragged through the Phasitron. The
circuit is a single line connected to the IPV device (2). The face
mask (3) was adjusted to the patient. Humidification was provided
by the nebuliser (4). Only two parameters were set, pressurisation
frequency (250 cycles/min) and driving pressure (1.2 bar). The
FiO2 was to obtain adequate oxygenation via the blender (5). Flow
at the airway opening was measured using a heated pneumotach-
ograph (6) and a differential pressure transducer (7) placed between
the mask and the ventilator tubing. All parameters were recorded
and analysed on a personal computer
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Statistics
Data are described as median and interquartile range
[25th–75th percentiles]. Measurements were made at
stability. The last 5 min of each measurement session was
taken into account for the analysis. Owing to the small
number of patients (\30), we used non-parametric anal-
ysis of variance and two-by-two tests. When tested, the
distribution was not normally distributed for several
variables. We compared NIV, IPV, spontaneous breathing
(SB), intermediate SB (ISB), and final SB (FSB) sessions
with a Friedman (non-parametric) analysis of variance.
When positive, we performed two-by-two comparisons
between periods using the Wilcoxon test. We first
checked that there was no difference for any comparison
between the three spontaneous breathing periods. We then
compared IPV or NIV to all SB periods. Data were ana-
lysed with SPSS16.0 for Windows statistical software
(SPSS Inc., Chicago, IL, USA). To correct for multiple
comparisons (Bonferroni correction), we considered a




We included 17 patients (Table 1). All patients tolerated
the experimental procedure well. Eight patients received
IPV first and nine received NIV first. Six patients had
COPD and had mild respiratory acidosis after extubation.
The most frequent reason for intubation was heart failure.
The APACHE II score was relatively high at inclusion, 15
[14–18].
Tolerance
Both NIV and IPV were well tolerated. None of the
patients reported breathing difficulties with either
modality. One patient complained that IPV was too noisy.
The median comfort score was 3 for both IPV and NIV.
One patient required re-intubation after 6 h for respiratory
muscle weakness due to ICU-acquired paresis and diffi-
culty clearing secretions.
Effects on oxygenation and ventilation
IPV and NIV caused significant reductions in median
respiratory rate, from 23 [19–27] to 22 [17–24] breaths/
min for IPV and from 25 [19–28] to 20 [18–22] breaths/
min for NIV (p \ 0.01 for both) (Fig. 2).
Arterial blood gas values were obtained in 13 patients.
Neither IPV nor NIV significantly changed the PaO2/FiO2
ratio (see Fig. S2 in the ESM). Median PaCO2 decreased
significantly with NIV (46 [42–48] vs. 41 [36–42] mmHg,
p \ 0.01), but did not change significantly with IPV
(Fig. 3). Likewise, in the subgroup of hypercapnic
patients with mild acidosis after extubation, IPV did not
significantly reduce PaCO2.
Table 1 Characteristics of the 17 patients at enrolment
Variables
Age (years) 73 [58–75]
Gender (M/F) 14/3
APACHE II at inclusion 15 [14–18]
COPD 6/17 (35%)
RR (breaths/min) 25 [19–28]
HR (beats/min) 94 [89–108]
pH 7.38 [7.37–7.40]
PaCO2 (mmHg) 46 [42–48]
PaO2/FiO2 (mmHg) 266 [204–282]







APACHE II Acute Physiology and Chronic Health Evaluation II,
COPD chronic obstructive pulmonary disease, RR respiratory rate,
HR heart rate
Values are medians [25th–75th percentiles]
Fig. 2 Box plots summarising respiratory rate variation during
different respiratory sessions. Box plots show median, interquartile
range (25th–75th percentiles), and outliers (5th–95th percentiles) of
respiratory rate in different ventilatory periods. RR respiratory rate,
SB spontaneous breathing, IPV intrapulmonary percussive ventila-
tion, ISB intermediate spontaneous breathing, NIV non-invasive
ventilation, FSB final spontaneous breathing period. *p \ 0.01
versus SB (Wilcoxon test)
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Effects on diaphragmatic work
Significant decreases in Pdi, PTPdi/breath, and PTPdi/min
occurred with both IPV and NIV (Fig. 4, Table 2).
Median PTPdi/min decreased with NIV from 273
[212–397] to 176 [120–216] cmH2O s/min and with IPV
from 264 [190–300] to 192 [152–221] cmH2O s/min
(p \ 0.01). PTPdi/breath and PTPdi/min were thus sig-
nificantly reduced, by about 35% with NIV and 20% with
IPV; the difference between NIV and IPV was not sig-
nificant (p = 0.15) (Fig. S3 in ESM).
Discussion
We found that IPV used for a short period unloaded the
inspiratory muscles in patients at high risk for re-intuba-
tion. When superimposed over spontaneous breathing,
IPV slightly changed the pattern of breathing and reduced
the work of breathing but did not modify alveolar
ventilation.
Diaphragmatic work
In this physiological study, NIV or IPV applied immedi-
ately after extubation significantly unloaded the
diaphragm, by approximately 35% with NIV and 20% with
IPV. To evaluate the respiratory muscle effort, we used
PTPdi/min, which correlates with inspiratory muscle
oxygen consumption [17]. Unloading was more pro-
nounced with NIV than with IPV. NIV has been shown to
both decrease the patient’s respiratory muscle effort by
providing adequate ventilatory support and increase alve-
olar ventilation [18–20]. The three periods of spontaneous
breathing enabled the patients to return to their baseline
Fig. 3 Box plots showing changes in PaCO2 during the study
measurement sessions in the 13 patients who underwent blood gas
analysis. The plots show the median, interquartile range (25th–75th
percentiles), and outliers (5th–95th percentiles) of PaCO2 values in
mmHg. SB spontaneous breathing, IPV intrapulmonary percussive
ventilation, ISB intermediate spontaneous breathing session, NIV
non-invasive ventilation, FSB final spontaneous breathing session.


















ventilation (IPV). The following
were recorded: Flow;
oesophageal pressure (Poes);





level between the ventilatory support sessions, which
avoided any bias caused by a ventilatory device effect.
The first physiological study of IPV was conducted by
Nava et al. [13] and established that the application of
IPV in 10 stable COPD patients was associated with a
significant reduction in diaphragm energy expenditure
(PTPdi/min and PTPdi/b) via a ventilatory effect. In
addition, in this study of 10-min-long IPV sessions,
15 min of spontaneous breathing between sessions was
sufficient to return the study parameters to the baseline
values [13]. In our study, 20 min of spontaneous breath-
ing was sufficient to return the parameters to baseline.
The decrease in effort was significant compared to all
spontaneous breathing periods.
Dellamonica et al. found an interesting physiological
effect after a 30-min IPV session in the immediate post-
extubation period in patients with COPD [31]: work of
breathing was not measured, but expiratory flow limita-
tion and airway occlusion pressure after 0.1 s (P0.1) were
both significantly improved. In our study, 20 min of IPV
slightly but significantly reduced the work of breathing.
This effect lasted only for as long as IPV was applied.
However, it would be of interest to evaluate the effect of
several IPV sessions or of longer IPV sessions.
Respiratory rate and gas exchange
We found that IPV or NIV induced significant changes in
the breathing pattern, which were more marked with NIV.
As previously reported, NIV was associated with a
decrease in the respiratory rate, and with increases in the
tidal volume and minute ventilation [20, 21]. A recent
review [20] found variations in the respiratory rate
response to NIV: in most studies, mean respiratory rate
decreased, on average by 6 breaths/min, whereas in a few
studies it remained unchanged. Several studies described
changes in breathing pattern induced by IPV [14, 22, 23].
In one study, 30 min of IPV after extubation significantly
decreased the respiratory rate [22]. Conceivably, the
rhythmic changes in airway pressure and vibrations of the
intercostal muscles may stimulate the mechanoreceptors,
inducing a reflex responsible for changes in breathing
control [22]. This hypothesis needs to be confirmed.
Both NIV and IPV maintained adequate PaO2/FiO2
values, but only NIV significantly decreased PaCO2. The
lack of an effect on oxygenation may be partly ascribable
to insufficient statistical power, as only 13 patients
underwent arterial blood gas measurement. Studies of
NIV consistently showed either significant improvements
or a trend toward improvements in oxygenation [13, 20,
24, 25]. NIV can enhance oxygenation and minute ven-
tilation via two mechanisms, namely respiratory muscle
unloading during inspiration and an increase in tidal
volume associated with an increase in alveolar ventilation
[21]. High-frequency percussive ventilation has been
shown to significantly improve the PaO2/FiO2 ratio in
several categories of patients, including burn patients
[26], obese patients with compression atelectasis [27],
patients with acute respiratory distress syndrome [9, 28],
newborns [9], tracheotomised patients [29], and postop-
erative patients [30].
Several mechanisms may explain the effects of IPV.
The first suggested benefit of IPV was a better clearance
of excessive bronchial and peripheral secretions, reducing
resistance and leading to enhanced ventilation [8, 10].
Two mechanisms may facilitate mucus clearance with
high-frequency oscillation: an increased mucus–flow
interaction leading to decrease in mucus viscoelasticity;
second, the transient change in air flow with each high-
frequency cycle could produce shearing at the air–mucus
interface and provide a cough-like force to the mucus
layer. An additional reflex effect of the high-frequency
oscillation on respiratory centres through chest wall or
airway receptors is another possible hypothesis that could
play a role.
An internal PEEP effect is also possible [13, 14]. As
Dellamonica et al. [31] point out, the level of PEEP
induced by IPV is very dependent on respiratory
mechanics and tidal volume (from 1.7 to 4.3 cmH2O),
using the same setting as in our study (1.2 bar and
250–300 cycles/min). On the basis of these results, it is
unlikely that intrinsic PEEP could have been higher than
4 or 5 cmH2O, the level used with NIV. In our study, the
levels of intrinsic PEEP during the pressure-support per-
iod and IPV periods were 1.6 cmH2O [1.1–2.2] during
NIV and 2.5 cmH2O [1.3–3.5] during IPV. This finding is
compatible with the results of the bench study. In the
post-extubation period, IPV has been shown to diminish
the expiratory flow limitation and the airway occlusion
pressure after 0.1 s, indicating a decrease in the work of
breathing [22]. These findings suggest that IPV may
Table 2 Effects on diaphragmatic work
SB NIV Intermediate SB IPV Final SB
Pdi (cmH2O) 9 [7–15] 5 [4–8]* 10 [6–12] 7 [5–10]* 8 [6–14]
PTPdi/breath (cmH2O s) 11 [8–14] 7 [6–11]* 10 [8–14] 9 [7–11]* 10 [9–12]
PTPdi/min (cmH2O s/min) 273 [212–397] 176 [120–216]* 264 [190–300] 192 [152–221]* 270 [216–288]
Values are medians [25th–75th percentiles]
* p \ 0.01 versus (SB; Intermediate SB and Final SB) (Wilcoxon test)
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provide additional ventilation and generate internal end-
expiratory pressure, two effects that may work together to
decrease the work of breathing. A comparison with con-
tinuous positive airway pressure (CPAP) could also have
been interesting.
IPV may thus constitute an alternative to NIV in this
period of prevention of post-extubation respiratory
distress.
Limitations
Comparisons of different ventilation modes must always
be considered with caution, as a given mode may have
different effects depending on the settings. We chose
settings that have been found effective in decreasing the
work of breathing [13]. A more detailed assessment of a
dose–response effect of this technique could be of interest
in the future. Adding IPV to conventional ventilation may
also decrease the humidity of the delivered gases. The
IPV device nebuliser does not provide adequate humidi-
fication [31, 32]. The Phasitron increases gas flow,
decreases gas temperature and, subsequently, lowers
absolute humidity. The current connection circuit does
not allow the connection of a heat and moisture exchan-
ger. The use of IPV for longer periods would require prior
improvements in the humidification system.
Conclusions
Prophylactic IPV sessions in a selected population at high
risk for re-intubation can decrease the diaphragmatic
energy expenditure. IPV used with these settings and in
non-acidotic patients is less effective than NIV in
improving alveolar ventilation. Nevertheless, IPV is a
relatively simple system that is easy to tolerate, does not
require a tight-fitting mask (which usually helps toler-
ance), and does not need synchronisation. IPV could
therefore be interesting for relieving dyspnea and
decreasing the work of breathing.
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